Impact and Lived Experience of Parents of a Child With a Large or Giant Congenital Melanocytic Nevus
PANGEA
1 other identifier
observational
30
1 country
1
Brief Summary
The goal of this observational study is to describe the experiences of parents at the birth of a child with a large or giant congenital melanocytic nevus through semi-structured interviews, and to identify potential intervention strategies to improve their care and support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2025
CompletedFirst Posted
Study publicly available on registry
April 18, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
December 30, 2025
December 1, 2025
6 months
April 6, 2025
December 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Results of the Semi-Structured Interviews with Parents
Analysis of the interview transcripts = verbatim analysis Individual semi-structured interviews will be conducted via videoconference, with an estimated duration of 30 minutes to 1 hour. An interview guide has been developed to define the key dimensions to be explored. Each interview will be audio-recorded using a voice recorder and then fully transcribed. The interviews will undergo a thematic content analysis to identify meaningful patterns ("nodes of meaning") within participants' narratives, using an inductive approach. A double coding will be performed by two investigators on five interviews to strengthen the thematic framework. The remaining interviews will be coded by a single investigator
Socio-demographic data and interview transcripts will be collected during the semi-structured interviews (lasting between 30 minutes and 1 hour), thus at a single time point (Day 1). No follow-up is required.
Study Arms (1)
Children with congenital melanocytic nevus
Interventions
There is no intervention
Eligibility Criteria
We will include parents of children with a large or giant congenital melanocytic nevus who are being followed at the university hospitals (CHRU) of Nancy, Marseille, Nantes, Dijon, Necker, Nice, Brest, Annecy, Grenoble and Saint Pierre.
You may qualify if:
- Aged 18 years or older
- Willing to participate in a semi-structured interview
- Has received full information about the research and has not objected to participating or to the use of their data
- Able to understand and speak French
- Parent of a child under 18 years of age
You may not qualify if:
- Under 18 years of age
- Not willing to participate
- Currently under legal protection (e.g., guardianship or curatorship)
- Cognitive and/or psychological impairments preventing participation in a semi-structured interview
- Poor understanding and/or expression of the French language
- Parent of a child over 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central Hospital, Nancy, Francelead
- Assistance Publique Hopitaux De Marseillecollaborator
- Hôpital Necker-Enfants Maladescollaborator
- Centre Hospitalier Universitaire de Nicecollaborator
- University Hospital, Brestcollaborator
- Annecy Hospital, Francecollaborator
- Centre Hospitalier Universitaire Dijoncollaborator
- Nantes University Hospitalcollaborator
- University Hospital, Grenoblecollaborator
- Centre Hospitalier Universitaire de la Réunioncollaborator
Study Sites (1)
Centre Hospitalier Régional Universitaire de Nancy
Nancy, France, 54035, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor and Principal Investigator
Study Record Dates
First Submitted
April 6, 2025
First Posted
April 18, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
December 30, 2025
Record last verified: 2025-12